Cargando…

Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome

BACKGROUND: Metabolic syndrome (MetS) is a clinical condition potentially promoting the development of atherosclerotic disease. To date, the clinical impact of elevated serum homocysteine (Hcy) levels in MetS is still under discussion. The aim of this cross sectional study was to evaluate the relati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piazzolla, Giuseppina, Candigliota, Mafalda, Fanelli, Margherita, Castrovilli, Anna, Berardi, Elsa, Antonica, Gianfranco, Battaglia, Stefano, Solfrizzi, Vincenzo, Sabbà, Carlo, Tortorella, Cosimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815401/ https://www.ncbi.nlm.nih.gov/pubmed/31673296 http://dx.doi.org/10.1186/s13098-019-0484-0

Ejemplares similares

Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D
por: Piazzolla, Giuseppina, et al.
Publicado: (2017)

When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs
por: Volpe, Sara, et al.
Publicado: (2021)

Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
por: Piazzolla, Giuseppina, et al.
Publicado: (2022)

Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects
por: Crudele, Lucilla, et al.
Publicado: (2023)

Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study
por: Volpe, Sara, et al.
Publicado: (2022)

A large asymptomatic portal vein aneurysm in an old man
por: Schilardi, Andrea, et al.
Publicado: (2020)

Corticosteroids for Acute and Recurrent Idiopathic Pericarditis: Unexpected Evidences
por: Perrone, Antonio, et al.
Publicado: (2019)

Gender, BMI and fasting hyperglycaemia influence Monocyte to-HDL ratio (MHR) index in metabolic subjects
por: Battaglia, Stefano, et al.
Publicado: (2020)

Hyperhomocysteinemia independently causes and promotes atherosclerosis in LDL receptor-deficient mice
por: Guo, Hang-Yuan, et al.
Publicado: (2014)

AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects
por: De Matteis, Carlo, et al.
Publicado: (2021)

Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
por: Volpe, Sara, et al.
Publicado: (2023)

Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects
por: De Matteis, Carlo, et al.
Publicado: (2022)

Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis
por: Crudele, Lucilla, et al.
Publicado: (2022)

Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study
por: Volpe, Sara, et al.
Publicado: (2022)

Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis
por: Griñán, Raquel, et al.
Publicado: (2022)

Hyperhomocysteinemia Potentiates Hyperglycemia-Induced Inflammatory Monocyte Differentiation and Atherosclerosis
por: Fang, Pu, et al.
Publicado: (2014)

Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian Longitudinal Study on Aging
por: Solfrizzi, Vincenzo, et al.
Publicado: (2020)

Identification of a Novel Score for Adherence to the Mediterranean Diet That Is Inversely Associated with Visceral Adiposity and Cardiovascular Risk: The Chrono Med Diet Score (CMDS)
por: De Matteis, Carlo, et al.
Publicado: (2023)

Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?
por: Lisco, Giuseppe, et al.
Publicado: (2023)

Hyperhomocysteinemia and Accelerated Aging: The Pathogenic Role of Increased Homocysteine in Atherosclerosis, Osteoporosis, and Neurodegeneration
por: Alkaissi, Hussam, et al.
Publicado: (2023)

Association of prehypertension and hyperhomocysteinemia with subclinical atherosclerosis in asymptomatic Chinese: a cross-sectional study
por: Liu, Bo, et al.
Publicado: (2018)

Hyperhomocysteinemia, Suppressed Immunity, and Altered Oxidative Metabolism Caused by Pathogenic Microbes in Atherosclerosis and Dementia
por: McCully, Kilmer S.
Publicado: (2017)

GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation
por: Li, Jing, et al.
Publicado: (2018)

Thrombophilia in hyperhomocysteinemia
por: Sharma, Vishal, et al.
Publicado: (2010)

Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis
por: Rizzi, Luigi, et al.
Publicado: (2022)

Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study
por: Marti, Franziska, et al.
Publicado: (2011)

Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis
por: Custodero, Carlo, et al.
Publicado: (2022)

Early Detection of Subclinical Atherosclerosis: Hyperhomocysteinemia as a Promising Marker in Adolescents With Vitamin B Deficiency
por: Shirode, Parth S, et al.
Publicado: (2023)

Iodine Deficiency and Iodine Prophylaxis: An Overview and Update
por: Lisco, Giuseppe, et al.
Publicado: (2023)

Hyperhomocysteinemia: Anesthetic concerns
por: Aggarwal, Shiba, et al.
Publicado: (2014)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Hyperhomocysteinemia: Clinical Insights
por: Al Mutairi, Fuad
Publicado: (2020)

Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
por: Wang, Renqing, et al.
Publicado: (2017)

No Effect of Diet-Induced Mild Hyperhomocysteinemia on Vascular Methylating Capacity, Atherosclerosis Progression, and Specific Histone Methylation
por: Whalen, Courtney A., et al.
Publicado: (2020)

Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis
por: Lisco, Giuseppe, et al.
Publicado: (2022)

Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease
por: Liu, Chenggui, et al.
Publicado: (2015)

Single-cell RNA sequencing reveals B cell-T cell interactions in vascular adventitia of hyperhomocysteinemia-accelerated atherosclerosis
por: Ma, Xiaolong, et al.
Publicado: (2022)

Hyperhomocysteinemia and recurrent carotid stenosis
por: Hillenbrand, Renata, et al.
Publicado: (2008)

Cobalamin deficiency, hyperhomocysteinemia, and dementia
por: Werder, Steven F
Publicado: (2010)

Myriad Cardiac Manifestation of Hyperhomocysteinemia
por: Babu, Jai, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6a32e2upeki512uu4nmcmp6p19